.Common-Size Income Statement
Difficulty: Beginner
Celgene Corp., Common-Size Consolidated Income Statement
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | Net product sales | ||||||||||
| | Cost of goods sold, excluding amortization of acquired intangible assets | ||||||||||
| | Gross profit | % | | % | | % | | % | | % | |
| | Other revenue | ||||||||||
| | Research and development | ||||||||||
| | Selling, general and administrative | ||||||||||
| | Amortization of acquired intangible assets | ||||||||||
| | Acquisition related gains (charges) and restructuring, net | ||||||||||
| | Operating income | % | | % | | % | | % | | % | |
| | Interest and investment income, net | ||||||||||
| | Interest expense | ||||||||||
| | Other income (expense), net | ||||||||||
| | Other income and expense | % | | % | | % | | % | | % | |
| | Income before income taxes | % | | % | | % | | % | | % | |
| | Income tax provision | ||||||||||
| | Net income | % | | % | | % | | % | | % | |
